{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T22:13:06Z","timestamp":1773958386411,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1038\/s41577-020-0372-8","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T13:04:07Z","timestamp":1592399047000},"page":"451-452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Optimizing safety surveillance for COVID-19 vaccines"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-9046","authenticated-orcid":false,"given":"Rebecca E.","family":"Chandler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"372_CR1","unstructured":"Vaccine Confidence Project. State of vaccine confidence in the EU: 2018. Vaccine Confidence https:\/\/www.vaccineconfidence.org\/research-feed\/the-state-of-vaccine-confidence-in-the-eu-2018 (2018)."},{"key":"372_CR2","unstructured":"World Health Organization. Ten threats to global health in 2019. WHO https:\/\/www.who.int\/news-room\/feature-stories\/ten-threats-to-global-health-in-2019 (2019)."},{"key":"372_CR3","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41577-020-0323-4","volume":"20","author":"PJ Hotez","year":"2020","unstructured":"Hotez, P. J., Corry, D. B. & Bottazzi, M. E. COVID-19 vaccine design: the Janus face of immune enhancement. Nat. Rev. Immunol. 20, 347\u2013348 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"372_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","volume":"19","author":"Le,T Thanh","year":"2020","unstructured":"Thanh, Le,T. et al. The COVID-19 vaccine development landscape. Nat. Rev. Drug Discov. 19, 305\u2013306 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"372_CR5","unstructured":"European Medicines Agency. COVID-19: how EMA fast-tracks development support and approval of medicines and vaccines. EMA https:\/\/www.ema.europa.eu\/en\/news\/covid-19-how-ema-fast-tracks-development-support-approval-medicines-vaccines (2020)."},{"key":"372_CR6","unstructured":"World Health Organization. Annex 9: guidelines on clinical evaluation of vaccines: regulatory expectations. WHO https:\/\/www.who.int\/biologicals\/expert_committee\/WHO_TRS_1004_web_Annex_9.pdf?ua=1 (2017)."},{"key":"372_CR7","unstructured":"World Health Organization. Global vaccine safety blueprint 2.0 background research. WHO https:\/\/www.who.int\/vaccine_safety\/publications\/2019_Landscape_Analysis.pdf?ua=1 (2019)."},{"key":"372_CR8","unstructured":"World Health Organization. Global vaccine safety blueprint. WHO https:\/\/apps.who.int\/iris\/handle\/10665\/70919 (2012)."},{"key":"372_CR9","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1016\/j.vaccine.2013.05.027","volume":"31","author":"HS Izurieta","year":"2013","unstructured":"Izurieta, H. S. et al. Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines. Vaccine 31, 3623\u20133627 (2013).","journal-title":"Vaccine"},{"key":"372_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/INF.0b013e3181a6a511","volume":"358","author":"GA Poland","year":"2009","unstructured":"Poland, G. A., Ovsyannikova, I. G. & Jacobson, R. M. Adversomics: the emerging field of vaccine adverse event immunogenetics. Pediatr. Infect. Dis. J. 358, 431\u2013432 (2009).","journal-title":"Pediatr. Infect. Dis. J."}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41577-020-0372-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41577-020-0372-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41577-020-0372-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:59:58Z","timestamp":1684619998000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-020-0372-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["372"],"URL":"https:\/\/doi.org\/10.1038\/s41577-020-0372-8","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"17 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}